메뉴 건너뛰기




Volumn 4, Issue 170, 2008, Pages 1928-1936

Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians;Suivi de l'adhésion thérapeutique des patients hypertendus ou dyslipidémiques par les cercles de qualité médecins- pharmaciens

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; CARDIOVASCULAR RISK; DRUG MONITORING; DYSLIPIDEMIA; HUMAN; HYPERTENSION; MEDICAL RESEARCH; PATIENT COMPLIANCE; REVIEW;

EID: 52949131858     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (2)

References (22)
  • 1
    • 0001667150 scopus 로고    scopus 로고
    • The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care : The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
    • ALLHAT Officers and coordinators for the ALLHAT collaborative research group
    • ALLHAT Officers and coordinators for the ALLHAT collaborative research group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care : The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT). JAMA 2002;18:2998-307.
    • (2002) JAMA , vol.18 , pp. 2998-3307
  • 2
    • 0037420492 scopus 로고    scopus 로고
    • ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial - lipid lowering arm (ASCOT-LLA) : A multicentre randomised controlled trial
    • Sever PS, Dahlöf B, Poulter NR, et al. ; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian cardiac outcomes trial - lipid lowering arm (ASCOT-LLA) : A multicentre randomised controlled trial. Lancet 2003;361:1149-58.
    • (2003) Lancet , vol.361 , pp. 1149-1158
    • Sever, P.S.1    Dahlöf, B.2    Poulter, N.R.3
  • 3
    • 9144248446 scopus 로고    scopus 로고
    • Hypertension treatment and control in five European countries, Canada, and the United States
    • Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-7.
    • (2004) Hypertension , vol.43 , pp. 10-17
    • Wolf-Maier, K.1    Cooper, R.S.2    Kramer, H.3
  • 4
    • 42449133365 scopus 로고    scopus 로고
    • The CoLaus study : A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome
    • Firmann M, Mayor V, Vidal PM, et al. The CoLaus study : A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8:6.
    • (2008) BMC Cardiovasc Disord , vol.8 , pp. 6
    • Firmann, M.1    Mayor, V.2    Vidal, P.M.3
  • 6
    • 7444221935 scopus 로고    scopus 로고
    • Promouvoir l'adhésion au traitement du patient dans le cadre d'une collaboration pharmaciens et médecins.
    • Santschi V, Favrat B, Bugnon O, et al. Promouvoir l'adhésion au traitement du patient dans le cadre d'une collaboration pharmaciens et médecins. Med Hyg 2004;62:2069-73.
    • (2004) Med Hyg , vol.62 , pp. 2069-2073
    • Santschi, V.1    Favrat, B.2    Bugnon, O.3
  • 7
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence : Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence : Terminology and definitions. Value Health 2008;11:44-7.
    • (2008) Value Health , vol.11 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 8
    • 1642397582 scopus 로고    scopus 로고
    • Variations in patients' adherence to medical recommendations : A quantitative review of 50 years of research
    • DiMatteo MR. Variations in patients' adherence to medical recommendations : A quantitative review of 50 years of research. Med Care 2004;42:200-9.
    • (2004) Med Care , vol.42 , pp. 200-209
    • DiMatteo, M.R.1
  • 9
    • 33750301096 scopus 로고    scopus 로고
    • Medication adherence and persistence as the cornerstone of effective antihypertensive therapy
    • Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190-6.
    • (2006) Am J Hypertens , vol.19 , pp. 1190-1196
    • Burnier, M.1
  • 10
    • 44349111871 scopus 로고    scopus 로고
    • * Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments : Longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-7.
    • * Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments : Longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-7.
  • 11
    • 23944499073 scopus 로고    scopus 로고
    • Persistence with treatment in newly treated middle-aged patients with essential hypertension
    • Perreault S, Lamarre D, Blais L, et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother 2005;39:1401-8.
    • (2005) Ann Pharmacother , vol.39 , pp. 1401-1408
    • Perreault, S.1    Lamarre, D.2    Blais, L.3
  • 12
    • 0037166985 scopus 로고    scopus 로고
    • Long-term persistence in use of statin therapy in elderly patients
    • Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455-61.
    • (2002) JAMA , vol.288 , pp. 455-461
    • Benner, J.S.1    Glynn, R.J.2    Mogun, H.3
  • 13
    • 0041866608 scopus 로고    scopus 로고
    • Monitoring compliance in resistant hypertension : An important step in patient management
    • Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension : An important step in patient management. J Hypertens 2003;21(Suppl.):S37-42.
    • (2003) J Hypertens , vol.21 , Issue.SUPPL.
    • Burnier, M.1    Santschi, V.2    Favrat, B.3    Brunner, H.R.4
  • 14
    • 0035144723 scopus 로고    scopus 로고
    • Electronic compliance monitoring in resistant hypertension : The basis for rational therapeutic decisions
    • Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension : The basis for rational therapeutic decisions. J Hypertens 2001;19:335-41.
    • (2001) J Hypertens , vol.19 , pp. 335-341
    • Burnier, M.1    Schneider, M.P.2    Chioléro, A.3    Stubi, C.L.4    Brunner, H.R.5
  • 16
    • 33846415962 scopus 로고    scopus 로고
    • * Wetzels GE, Nelemans PJ, Scheuten JS, et al. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 2007;20:119-25.
    • * Wetzels GE, Nelemans PJ, Scheuten JS, et al. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 2007;20:119-25.
  • 17
    • 51449091027 scopus 로고    scopus 로고
    • Impact of electronic monitoring of drug adherence on blood pressure control in primary care : A 12 month randomised controlled study
    • sous presse
    • Santschi V, Rodondi N, Bugnon O, Burnier M. Impact of electronic monitoring of drug adherence on blood pressure control in primary care : A 12 month randomised controlled study. Eur J Intern Med 2008, sous presse.
    • (2008) Eur J Intern Med
    • Santschi, V.1    Rodondi, N.2    Bugnon, O.3    Burnier, M.4
  • 19
    • 7444240993 scopus 로고    scopus 로고
    • Les cercles de qualité médecins-pharmaciens : Un réseau local pour maîtriser les coûts et la qualité de la prescription médicale.
    • Bugnon O, Niqullle A, Repond C, Curty C, Nyffeler R. Les cercles de qualité médecins-pharmaciens : un réseau local pour maîtriser les coûts et la qualité de la prescription médicale. Med Hyg 2004;62:2054-8.
    • (2004) Med Hyg , vol.62 , pp. 2054-2058
    • Bugnon, O.1    Niqullle, A.2    Repond, C.3    Curty, C.4    Nyffeler, R.5
  • 20
    • 0033009996 scopus 로고    scopus 로고
    • Improved blood pressure control by monitoring compliance with antihypertensive therapy
    • Waeber B, Vetter W, Darioli R, Keller U, Brunner HR. Improved blood pressure control by monitoring compliance with antihypertensive therapy. Int J Clin Pract 1999;53:37-8.
    • (1999) Int J Clin Pract , vol.53 , pp. 37-38
    • Waeber, B.1    Vetter, W.2    Darioli, R.3    Keller, U.4    Brunner, H.R.5
  • 21
    • 0034937376 scopus 로고    scopus 로고
    • Treatment strategy to control blood pressure optimally in hypertensive patients
    • Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Press 2001;10:62-73.
    • (2001) Blood Press , vol.10 , pp. 62-73
    • Waeber, B.1
  • 22
    • 0034723758 scopus 로고    scopus 로고
    • The lipid treatment assessment project (L-TAP) : A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
    • Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP) : A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-67.
    • (2000) Arch Intern Med , vol.160 , pp. 459-467
    • Pearson, T.A.1    Laurora, I.2    Chu, H.3    Kafonek, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.